Skip to NavigationSkip to content's weekly COVID-19 news round-up

Published on 15/04/20 at 12:22pm
Image credit: CDC

Hydroxychloroquine dominates the latest coronavirus news this week. The anti-malaria drug, touted by President Trump as an effective COVID-19 treatment, has proved dangerous in a clinical trial in Brazil. Since Trump has praised the drug there has been an increase in misuse across the US. Critics have also alleged the President's continuous messaging about the treatment is motivated by his small financial link to Sanofi.

1. Critics say Trump pushing hydroxychloroquine due to his financial ties to manufacturers - Published on 08/04/2020

Critics are arguing that President Donald Trump is touting the malaria drug hydroxychloroquine as a COVID-19 treatment because he has financial links to manufacturers of the drug.

2. US reports increase in Hydroxychloroquine misuse - Published 09/04/2020

The American Association of Poison Control Centers (AAPCC) has said there has been an increase in people abusing the anti-malaria drug hydroxychloroquine, after being touted by President Donald Trump as a coronavirus treatment.

3. Fatal heart complications halt Brazilian study of chloroquine in treating COVID-19 - Published 14/04/2020

A chloroquine study investigating its effects in treating the COVID-19 coronavirus in Brazil has been postponed for safety reasons.

4. Gilead's promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients - Published 14/04/20

Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of its antiviral therapy remdesivir, one of the most promising treatments for patients hospitalised by COVID-19.

5. US to review its funding of the World Health Organization - Published 15/04/20

President Donald Trump has announced the US may stop funding the World Health Organization due to allegations that they covered up the spread of the pandemic.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches